维普中文期刊产品整合服务
27篇 您的检索式:作者名="Gough SC"
    题名 作者 年代 出处 被引量
1Delayed initiation ofsubcutaneous insulin therapy after failure of oral glucose-low-ering agents in patients with type 2 diabetes:a population-based analysis in the UK显示文摘Rubino A McQuay LJ Gough SC 2007Diabet Med2007,24,12:1
2The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily:a 26-week,randomized,openlabel,parallel-group,treat-to-target trial in individuals with type 2 diabetes显示文摘Meneghini L Atkin SL Gough SC 2013Diabetes care2013,36,4:1
3Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus 显示文摘Bennett ST Lucassen AM Gough SC et at 1995Nat Genet1995,9,3:1
4Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus 显示文摘Ballav C Gough SC 2013Clin Med Insights Endocrinol Diabetes2013,6,:1
5Insulin degludec:overview of a novel ultra long-acting basal insulin显示文摘Gough SC Harris S Woo V 2013Diabetes Obes Metab2013,15,4:1
6A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease 显示文摘Taylor JC Gough SC Hunt PJ 2006J Clin Endocrinol Metab2006,91,2:1
7Liraglutide:from clinical trials to clinical practice显示文摘Gough SC 2012Diabetes Obes Metab2012,14,2:1
8Susceptibility to human type 1 diabetes and IDDM2 is determined by tandem re-peat variation at the insulin gene minisatellite locus显示文摘Bennett ST Lucassen AM Gough SC 1995Nat Genet1995,9,3:1
9Hypoglycaemia risk w ith insulin degludec compared w ith insulin glargine in type 2and type 1 diabetes:a pre-planned meta-analysis of phase 3 trials显示文摘Ratner RE Gough SC Mathieu C 2013Diabetes Obes M etab2013,15,2:1
10Genetics of thyroid antoimmunity and the role of the TSHR显示文摘Brand OJ Gough SC 2010Mol Cell Endocrinol2010,322,:1
11Hypoglyeaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes a pre-planned meta-analysis of phase 3 tri als显示文摘Ratner RE Gough SC Mathieu C 2013Diabetes Obes Metab2013,15,2:1
12The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared w ith insulin glargine and insulin degludec dosed at the same time daily:a 26-w eek,randomized,open-label,parallel-group,treat-to-target trial in individuals w ith type2 diabetes显示文摘Meneghini L Atkin SL Gough SC 2013Diabetes Care2013,36,4:1
13A genomewide screen in 1119 relative pairs with autoimmune thyroid disease显示文摘TAYLOR JC GOUGH SC HUNT PJ 2006Clin Endocrinol Metab2006,91,2:1
14Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes:a pre-planned meta-analysis of phase 3 trials显示文摘Ratner RE Gough SC Mathieu LC 2013Diabetes Obes Metab2013,15,2:1
15Unravelling the genetic complexity of autoimmune thyroid diease : HLA,CTLA - 4 and beyond 显示文摘Simmonds M J Gough SC 2004Clin Exp Immunol2004,136,1:1
16Low-volume insulin degludec 200 units/m L once daily improves glycemic control similarly to insulin glargine w ith a low risk of hypoglycemia in insulin-naive patients w ith type 2 diabetes:a 26-w eek,randomized,controlled,multinational,treat-to-target trial:the BEGIN LOW VOLUM E trial显示文摘Gough SC Bhargava A Jain R 2013Diabetes Care2013,36,9:1
17Unravelling the genetic complexity of autoimmune thyroid diease : HLA ,CTLA-4 and beyond 显示文摘Simmonds MJ Gough SC 2004Clin Exp Immunol2004,136,1:1
18Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes : a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial显示文摘Gough SC Bhargava A Jain R 2013Diabetes Care2013,36,9:1
19CTLA4 gene polymorphism and autoimmunity 显示文摘Gough SC Walker LS Sansom DM 2005Immunol Rev2005,204,1:1
20The relationship between plasminogen activator inhibitor-1 and insulin resistence in newly diagnosed type 2 diabetes mellitus显示文摘Gough SC Rice PJ McCormack L 1993Diabet Med1993,10,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费